Screener
Amylyx Pharmaceuticals, Inc. AMLX Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s invested capital?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported invested capital of $195.1M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s invested capital increased by 68.5% year-over-year, from $115.75M to $195.1M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s invested capital?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s invested capital has grown at a -33.3% compound annual growth rate (CAGR), from $284.36M to $84.57M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Amylyx Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude